Affiliations 

  • 1 Malaysian Association for Family and Child Health (MAFCH), Kuala Lumpur, Malaysia. sharavanyad@gmail.com
  • 2 Vaccines Medical and Scientific Affairs, Pfizer Biopharma, Collegeville, Pennsylvania, USA
  • 3 Emerging Markets Region Medical Affairs, Pfizer Biopharma, New York City, USA
  • 4 Pfizer Biopharma, Kuala Lumpur, Malaysia
  • 5 Malaysian Association for Family and Child Health (MAFCH), Kuala Lumpur, Malaysia
BMC Infect Dis, 2024 Jan 12;24(1):79.
PMID: 38216882 DOI: 10.1186/s12879-023-08611-3

Abstract

BACKGROUND: Pneumococcal disease caused by Streptococcus pneumoniae is an important cause of morbidity and mortality across all ages, particularly in younger children and older adults. Here, we describe pneumococcal disease hospitalizations at Ministry of Health (MoH) facilities in Malaysia between 2013 and 2015.

METHODS: This was a retrospective databases analysis. Tabular data from the Malaysian Health Data Warehouse (MyHDW) were used to identify microbiologically confirmed, pneumococcal disease hospitalizations and deaths during hospitalization, using hospital-assigned ICD-10 codes (i.e., classified as meningitis, pneumonia, or non-meningitis non-pneumonia). Case counts, mortality counts, and case fatality rates were reported by patient age group and by Malaysian geographic region.

RESULTS: A total of 683 pneumococcal disease hospitalizations were identified from the analysis: 53 pneumococcal meningitis hospitalizations (5 deaths and 48 discharges), 413 pneumococcal pneumonia hospitalizations (24 deaths and 389 discharges), and 205 non-meningitis non-pneumonia pneumococcal disease hospitalizations (58 deaths and 147 discharges). Most hospitalizations occurred in children aged 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.